DUBLIN--(BUSINESS WIRE)--The "Organ-on-Chip Market by Type (Heart-on-chip, Human-on-chip, Intestine-on-chip, Kidney-on-chip, Liver-on-chip, and Lung-on-chip) - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to Research and Markets' offering.
Organ-on-chip a multichannel 3D micro-fluidic cell culture device, which simulates activities, mechanisms, and physiological responses of human organs. This chip develops a narrow channel for the blood and air flow in organs including lung, gut, liver, heart, and others. This devices is developed on a microchip that contains continuously perfused chambers colonized by living cells arranged to stimulate tissue- and organ-level physiology. It is used to nurture internal organs with the help of silicone.
The growth of the global organ-on-chip market is driven by increase in its applications in the healthcare sector, rise in demand for drug screening, and high demand for lung-based organ culture & kidney applications. However, high cost and nascent stage in R&D restrict the market growth. Conversely, increase in research activities on organ-on-chip is expected to offer ample opportunities to the key players.
The global organ-on-chip market is segmented on the basis of type and geography. Depending on type, the market is divided into heart-on-chip, human-on-chip, intestine-on-chip, kidney-on-chip, liver-on-chip, and lungs-on-chip. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Companies Mentioned:
- Axosim Technologies Llc
- CN Innovations Holdings Limited (CN Bio Innovations)
- Emulate, Inc.
- Ascendance BIoTechnology, Inc.
- Hurel Corporation
- Insphero AG
- Mimetas B.V.
- Nortis Inc.
- Organovo Holdings, Inc.
- Tara Biosystems, Inc.
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Market Overview
4 Organ-on-Chip Market, by Type
5 Organ-on-Chip Market, by Geography
6 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/fcv9v5/organonchip
